您当前的位置：
首页 >
文章列表页 >
Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways
COMMENTARY | 更新时间：2025-12-13
上一篇|下一篇

    • Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways

    • Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways

    • “在xxx领域，xx专家取得了重大的研究进展。他们建立了xx体系/探索了xx主题/验证了xx猜想，为解决xx问题提供了解决方案，为xx的未来研究铺平了道路。”
    • Mabel L. Cummins ，Grace Delmonte ，Skylar Wechsler ，Joseph J. Schlesinger
    • MMR 2025年12卷第4期 页码：633-635

    • DOI： 10.1186/s40779-024-00513-y     

      中图分类号：

    移动端阅览

  •  
  •  

  • AI导读

  • HTML全文

  • 参考文献

  • 出版信息

  • 数据统计

48

浏览量

19

下载量

0

CSCD

文章被引用时，请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy
Better therapy for combat injury
Effects of interleukin-1α on platelet-derived growth factor release from bovine cerebral microvascular endothelial cells
Engineering of functional auditory neurons from human induced pluripotent stem cells

相关作者

Yang Cao
Dong-Dong Sun
Xuan Zhang
Xiao-Ming Gu
Cong-Ye Li
Xiao Zhang
Hao Wang
Lei Xin

相关机构

Department of Cardiology, Xijing Hospital, Air Force Medical University
Department of Basic Medicine, Air Force Medical University
Department of Physiology and Pathophysiology, Air Force Medical University
Institute for Hospital Management Research, Chinese PLA General Hospital
Department of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research, Albert Einstein College of Medicine